Pressure-Support Ventilation vs T-Piece During Spontaneous Breathing Trials Before Extubation Among Patients at High Risk of Extubation Failure: A Post-Hoc Analysis of a Clinical Trial.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
10 2020
Historique:
received: 31 12 2019
revised: 01 04 2020
accepted: 20 04 2020
pubmed: 23 5 2020
medline: 4 6 2021
entrez: 23 5 2020
Statut: ppublish

Résumé

Spontaneous breathing trial (SBT) using a T-piece remains the most frequently performed trial before extubation in ICUs. We aimed at determining whether initial SBT using pressure-support ventilation (PSV) could increase successful extubation rates among patients at high risk of extubation failure. Post hoc analysis of a multicenter trial focusing on reintubation in patients at high-risk of extubation failure. The initial SBT was performed using PSV or T-piece according to the physician/center decision. The primary outcome was the proportion of patients successfully extubated 72 hours after initial SBT, that is, extubated after initial SBT and not reintubated within the following 72 hours. Among the 641 patients included in the original study, initial SBT was performed using PSV (7.0 cm H In patients at high risk of extubation failure in the ICU, performing an initial SBT using PSV may hasten extubation without an increased risk of reintubation.

Sections du résumé

BACKGROUND
Spontaneous breathing trial (SBT) using a T-piece remains the most frequently performed trial before extubation in ICUs.
RESEARCH QUESTION
We aimed at determining whether initial SBT using pressure-support ventilation (PSV) could increase successful extubation rates among patients at high risk of extubation failure.
STUDY DESIGN AND METHODS
Post hoc analysis of a multicenter trial focusing on reintubation in patients at high-risk of extubation failure. The initial SBT was performed using PSV or T-piece according to the physician/center decision. The primary outcome was the proportion of patients successfully extubated 72 hours after initial SBT, that is, extubated after initial SBT and not reintubated within the following 72 hours.
RESULTS
Among the 641 patients included in the original study, initial SBT was performed using PSV (7.0 cm H
INTERPRETATION
In patients at high risk of extubation failure in the ICU, performing an initial SBT using PSV may hasten extubation without an increased risk of reintubation.

Identifiants

pubmed: 32439503
pii: S0012-3692(20)31401-X
doi: 10.1016/j.chest.2020.04.053
pii:
doi:

Types de publication

Clinical Trial Comparative Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1446-1455

Investigateurs

Florence Boissier (F)
Delphine Chatellier (D)
Céline Deletage (C)
Carole Guignon (C)
Florent Joly (F)
Morgane Olivry (M)
Anne Veinstein (A)
Dalila Benzekri-Lefevre (D)
Thierry Boulain (T)
Grégoire Muller (G)
Yves Le Tulzo (Y)
Jean-Marc Tadié (JM)
Adel Maamar (A)
Suela Demiri (S)
Julien Mayaux (J)
Maxens Decavèle (M)
Lila Bouadma (L)
Claire Dupuis (C)
Pierre Asfar (P)
Marc Pierrot (M)
Gaëtan Béduneau (G)
Déborah Boyer (D)
Benjamin Delmas (B)
Bérénice Puech (B)
Konstantinos Bachoumas (K)
Edouard Soum (E)
Séverin Cabasson (S)
Marie-Anne Hoppe (MA)
Saad Nseir (S)
Olivier Pouly (O)
Gaël Bourdin (G)
Sylvène Rosselli (S)
Anthony Le Meur (A)
Charlotte Garret (C)
Maelle Martin (M)
Guillaume Berquier (G)
Abirami Thiagarajah (A)
Guillaume Carteaux (G)
Armand Mekontso-Dessap (A)
Antoine Poidevin (A)
Anne-Florence Dureau (AF)
Marie-Ange Azais (MA)
Gwenhaël Colin (G)
Emmanuelle Mercier (E)
Marlène Morisseau (M)
Caroline Sabatier (C)
Walter Picard (W)
Marc Gainnier (M)
Thi-My-Hue Nguyen (TM)
Gwenaël Prat (G)
Carole Schwebel (C)
Matthieu Buscot (M)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Arnaud W Thille (AW)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers, France; INSERM Centre d'Investigation Clinique 1402 ALIVE, Université de Poitiers, Poitiers, France. Electronic address: aw.thille@gmail.com.

Rémi Coudroy (R)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers, France; INSERM Centre d'Investigation Clinique 1402 ALIVE, Université de Poitiers, Poitiers, France.

Mai-Anh Nay (MA)

Centre Hospitalier Régional d'Orléans, Médecine Intensive Réanimation, Orléans, France.

Arnaud Gacouin (A)

Centre Hospitalier Universitaire de Rennes, Hôpital Ponchaillou, Service des Maladies Infectieuses et Réanimation Médicale, Rennes, France.

Alexandre Demoule (A)

Hôpital Pitié-Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation (Département R3S), UMRS1158 neurophysiologie respiratoire expérimentale et clinique, Sorbonne Université, Paris, France.

Romain Sonneville (R)

Hôpital Bichat-Claude Bernard, Médecine Intensive Réanimation, Université Paris Diderot, Paris, France.

François Beloncle (F)

Centre Hospitalier Universitaire d'Angers, Département de Médecine Intensive Réanimation, Université d'Angers, Angers, France.

Christophe Girault (C)

Centre Hospitalier Universitaire de Rouen, Hôpital Charles Nicolle, Département de Réanimation Médicale, Normandie Université, Institute for Research and Innovation in Biomedicine (IRIB), Rouen, France.

Laurence Dangers (L)

Centre Hospitalier Universitaire Félix Guyon, Service de Réanimation Polyvalente, Saint Denis de la Réunion, France.

Alexandre Lautrette (A)

Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Gabriel Montpied, Service de Réanimation Médicale, Clermont-Ferrand, France.

Quentin Levrat (Q)

Centre Hospitalier de La Rochelle, Service de Réanimation, La Rochelle, France.

Anahita Rouzé (A)

Centre Hospitalier Universitaire de Lille, Centre de Réanimation, Université de Lille, Lille, France.

Emmanuel Vivier (E)

Hôpital Saint-Joseph Saint-Luc, Réanimation Polyvalente, Lyon, France.

Jean-Baptiste Lascarrou (JB)

Centre Hospitalier Universitaire de Nantes, Médecine Intensive Réanimation, Nantes, France.

Jean-Damien Ricard (JD)

Hôpital Louis Mourier, Réanimation Médico-Chirurgicale, Université Paris Diderot, Sorbonne Paris Cité, Colombes, France.

Keyvan Razazi (K)

Hôpitaux universitaires Henri Mondor, Service de Réanimation Médicale DHU A-TVB, Créteil, France.

Guillaume Barberet (G)

Groupe Hospitalier Régional Mulhouse Sud Alsace, site Emile Muller, Service de Réanimation Médicale, Mulhouse, France.

Christine Lebert (C)

Centre Hospitalier Départemental de Vendée, Service de Médecine Intensive Réanimation, La Roche Sur Yon, France.

Stephan Ehrmann (S)

Centre Hospitalier Régional Universitaire de Tours, Médecine Intensive Réanimation, Réseau CRICS-Trigger SEP, Centre d'étude des pathologies respiratoires, Université de Tours, Tours, France.

Alexandre Massri (A)

Centre Hospitalier de Pau, Service de Réanimation, Pau, France.

Jeremy Bourenne (J)

Centre Hospitalier Universitaire La Timone 2, Médecine Intensive Réanimation, Réanimation des Urgences, Aix-Marseille Université, Marseille, France.

Gael Pradel (G)

Centre Hospitalier Henri Mondor d'Aurillac, Service de Réanimation, Aurillac, France.

Pierre Bailly (P)

Centre Hospitalier Universitaire de Brest, Médecine Intensive Réanimation, Brest, France.

Nicolas Terzi (N)

Centre Hospitalier Universitaire Grenoble Alpes, Médecine Intensive Réanimation, INSERM, Université Grenoble-Alpes, Grenoble, France.

Jean Dellamonica (J)

Centre Hospitalier Universitaire de Nice, Médecine Intensive Réanimation, Archet 1, Université Cote d'Azur, Nice, France.

Guillaume Lacave (G)

Centre Hospitalier de Versailles, Service de Réanimation Médico-Chirurgicale, Le Chesnay, France.

René Robert (R)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers, France; INSERM Centre d'Investigation Clinique 1402 ALIVE, Université de Poitiers, Poitiers, France.

Stéphanie Ragot (S)

INSERM Centre d'Investigation Clinique 1402 ALIVE, Université de Poitiers, Poitiers, France.

Jean-Pierre Frat (JP)

Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers, France; INSERM Centre d'Investigation Clinique 1402 ALIVE, Université de Poitiers, Poitiers, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH